Microvascular decompression for trigeminal neuralgia: a long-term follow-up study

M N Pamir1, S Peker

  • 1Department of Neurosurgery, Marmara University Medical School, Marmara University Neurological Sciences Institute, Istanbul, Turkey.

Insights

Microvascular decompression (MVD) effectively treats trigeminal neuralgia (TN). This surgical approach offers significant pain relief for most patients, with no associated mortality, making it a recommended first-line treatment.

Area of Science:

  • Neurosurgery
  • Neurology

Background:

  • Trigeminal neuralgia (TN) is a debilitating condition characterized by facial pain.
  • Microvascular decompression (MVD) is a surgical option for TN.
  • Factors influencing recurrence after MVD require further investigation.

Purpose of the Study:

  • To present the experience with MVD for idiopathic TN.
  • To identify factors associated with recurrence after MVD.
  • To evaluate the efficacy and safety of MVD for TN.

Main Methods:

  • Retrospective review of 90 patients with idiopathic TN who underwent MVD between 1986 and 2004.
  • Exclusion of patients with atypical or secondary TN.
  • Analysis of patient characteristics, surgical findings, and outcomes.

Main Results:

  • Vascular compression of the trigeminal nerve was identified in 97% of patients.
  • Arterial compression was more common (92%) than venous compression (8%).
  • Complete symptom resolution occurred in 77 patients; partial relief in 10 patients. No improvement in 3 patients. No mortality was reported.

Conclusions:

  • MVD is an effective and reliable treatment for trigeminal neuralgia.
  • Vascular compression is the primary cause of TN in most cases.
  • MVD is recommended as a first-line surgical treatment for medically refractory TN.

Related Concept Videos